晚期帕金森患者中持续多巴胺能药物应用不能满足治疗需要。
Continuous dopaminergic drug delivery is an unmet medical need in advanced Parkinson's disease.
因此，关于多巴胺能药物在治疗泌乳素瘤时对心血管的不利影响的附加研究结果是肯定的，特别是使用这些药物足够长时间的病人。
Therefore, additional studies on the adverse cardiac effects of dopaminergic drugs in prolactinoma are warranted, especially in patients with much longer use of these drugs.
尽管目前存在药物治疗的缺陷，但是多巴胺能神经元的替代治疗呈现出广阔的前景。
At present, pharmaceutical therapy has various shortcomings, while the replacement therapy of dopaminergic neurons shows competitive prospect.
撤药反应的出现可能与药物对中枢神经系统中血清素、多巴胺、去甲肾上腺素、GABA、胆碱能类递质系统的影响有关。
Appearance of withdrawal reactions may associated with pharmacological effects on serotonin, dopamine, norepinephrine, GABA and cholinergic transmitter in central nervous system.
撤药反应的出现可能与药物对中枢神经系统中血清素、多巴胺、去甲肾上腺素、GABA、胆碱能类递质系统的影响有关。
Appearance of withdrawal reactions may associated with pharmacological effects on serotonin, dopamine, norepinephrine, GABA and cholinergic transmitter in central nervous system.
应用推荐